From Phytochemistry to Metabolic Regulation: The Insulin-Promoting Effects of Loureirin B Analogous to an Agonist of GLP-1 Receptor
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311548 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Haowen Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China. Hauptthemen laut MEDLINE: Insulin, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Agriculture Project.
Abstract (Originalsprache)
This study aimed to develop a potent, safe, and cost-effective small-molecule hypoglycemic agent derived from Loureirin B, with preliminary evaluation of its efficacy and mechanistic underpinnings. Thirty structural analogs of Loureirin B were synthesized. Molecular docking identified LB-A as the lead compound targeting GLP-1R. Its hypoglycemic activity was initially assessed in a murine model. Molecular dynamics simulations, surface plasmon resonance (SPR), and circular dichroism (CD) were employed to characterize LB-A–GLP-1R interactions. The involvement of the GLP-1R/cAMP/PKA pathway and downstream mediators was examined using cellular assays, gene knockout, and Western blotting, with emphasis on FOXO1. LB-A exhibited the strongest binding affinity for GLP-1R among the analogs and significantly reduced blood glucose levels in mice. It formed hydrogen bonds and hydrophobic interactions with key residues (e.g., LYS197) and induced conformational changes in GLP-1R. LB-A activation of GLP-1R upregulated cAMP, PKA, and pCREB, suppressed PTEN/FOXO1 signaling, and subsequently stimulated insulin secretion. LB-A represents a novel small molecule agonist that ameliorates hyperglycemia in diabetic mice through specific activation of the GLP-1R/cAMP/PKA/pCREB/PTEN/FOXO1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.
- School of Life Sciences, Shanghai University, Shanghai 200444, China.
- Shanghai Engineering Research Center of Organ Repair, Joint International Research Laboratory of Biomaterials and Biotechnology in Organ Repair (Ministry of Education), School of Medicine, Shanghai University, Shanghai…
ORCID-Profile: Qin Chen
Förderung
- Shanghai Agriculture Project
Zitieren
APA
Fang, H., Sun, X., Ding, Y., Gu, S., Niu, B., & Chen, Q. (2025). From Phytochemistry to Metabolic Regulation: The Insulin-Promoting Effects of Loureirin B Analogous to an Agonist of GLP-1 Receptor. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311548
Vancouver
Fang H, Sun X, Ding Y, Gu S, Niu B, Chen Q. From Phytochemistry to Metabolic Regulation: The Insulin-Promoting Effects of Loureirin B Analogous to an Agonist of GLP-1 Receptor. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311548
BibTeX
@article{Fang2025,
author = {Fang, Haowen and Sun, Xiaodong and Ding, Yanting and Gu, Siyuan and Niu, Bing and Chen, Qin},
title = {From Phytochemistry to Metabolic Regulation: The Insulin-Promoting Effects of Loureirin B Analogous to an Agonist of GLP-1 Receptor},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311548}
}
EUVIMED